A. Fabre

F. Clavel-Chapelon, M. Boutron‐Ruault, G. Fagherazzi, 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Postmenopausal hormone therapy and asthma onset in the E 3 N cohort Running Title : Hormone therapy and asthma

A. Fournier, I. Romieu, B. Leynaert, 2019 .

Oral progestagens before menopause and breast cancer risk

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2007, British Journal of Cancer.

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.

F. Clavel-Chapelon, A. Fournier, E. Riboli, 2010, American journal of epidemiology.

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union

A. Bryant, R. Brody, C. Liss, 2017, International clinical psychopharmacology.

Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)

J. Benichou, F. Limosin, G. Vaiva, 2012, Schizophrenia Research.

Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

J. Chang-Claude, F. Clavel-Chapelon, A. Fournier, 2011, International journal of cancer.

An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study

N. Ngah, T. Lai, H. Yu, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.

Françoise Clavel-Chapelon, F. Clavel-Chapelon, A. Fournier, 2011, American journal of epidemiology.

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.

L. Salomon, Y. Allory, C. Abbou, 2012, Urology.

Hormonal Therapy and Risk of Breast Cancer in Mexican Women

P. Hainaut, I. Romieu, C. Biessy, 2013, PloS one.

Is Saliva a Good Alternative to Blood for High Density Genotyping Studies: SNP and CNV Comparisons?

S. Ragusa, D. Cox, E. Thomas, 2011 .

Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Cancer Epidemiology Biomarkers & Prevention.

Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women.

F. Clavel-Chapelon, I. Romieu, M. Boutron‐Ruault, 2008, The American journal of clinical nutrition.

American Journal of Epidemiology Original Contribution Risk of Osteoporotic Fractures after Discontinuation of Menopausal Hormone Therapy: Results from the E3n Cohort

S. Mesrine, M. Boutron‐Ruault, P. Engel, 2022 .

Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Cancer Epidemiology Biomarkers & Prevention.